"Dinitrobenzenes" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Benzene derivatives which are substituted with two nitro groups in the ortho, meta or para positions.
| Descriptor ID |
D004136
|
| MeSH Number(s) |
D02.455.426.559.389.565.225 D02.640.529.240
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Dinitrobenzenes".
Below are MeSH descriptors whose meaning is more specific than "Dinitrobenzenes".
This graph shows the total number of publications written about "Dinitrobenzenes" by people in this website by year, and whether "Dinitrobenzenes" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 2 | 2 |
| 1998 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dinitrobenzenes" by people in Profiles.
-
Buchel G, Nayak AR, Herbine K, Sarfallah A, Sokolova VO, Zamudio-Ochoa A, Temiakov D. Structural basis for DNA proofreading. Nat Commun. 2023 12 27; 14(1):8501.
-
Newmeyer MN, Concheiro M, Huestis MA. Rapid quantitative chiral amphetamines liquid chromatography-tandem mass spectrometry: method in plasma and oral fluid with a cost-effective chiral derivatizing reagent. J Chromatogr A. 2014 Sep 05; 1358:68-74.
-
Berd D, Sato T, Maguire HC, Kairys J, Mastrangelo MJ. Immunopharmacologic analysis of an autologous, hapten-modified human melanoma vaccine. J Clin Oncol. 2004 Feb 01; 22(3):403-15.
-
Manne J, Mastrangelo MJ, Sato T, Berd D. TCR rearrangement in lymphocytes infiltrating melanoma metastases after administration of autologous dinitrophenyl-modified vaccine. J Immunol. 2002 Sep 15; 169(6):3407-12.
-
Berd D, Kairys J, Dunton C, Mastrangelo MJ, Sato T, Maguire HC. Autologous, hapten-modified vaccine as a treatment for human cancers. Semin Oncol. 1998 Dec; 25(6):646-53.
-
Sato T, Bullock TN, Eisenlohr LC, Mastrangelo MJ, Berd D. Dinitrophenyl-modified autologous melanoma vaccine induces a T cell response to hapten-modified, melanoma peptides. Clin Immunol Immunopathol. 1997 Dec; 85(3):265-72.
-
Dombrowicz D, Flamand V, Miyajima I, Ravetch JV, Galli SJ, Kinet JP. Absence of Fc epsilonRI alpha chain results in upregulation of Fc gammaRIII-dependent mast cell degranulation and anaphylaxis. Evidence of competition between Fc epsilonRI and Fc gammaRIII for limiting amounts of FcR beta and gamma chains. J Clin Invest. 1997 Mar 01; 99(5):915-25.
-
Sato T, Maguire HC, Mastrangelo MJ, Berd D. Human immune response to DNP-modified autologous cells after treatment with a DNP-conjugated melanoma vaccine. Clin Immunol Immunopathol. 1995 Jan; 74(1):35-43.
-
Berd D, Maguire HC, Mastrangelo MJ, Murphy G. Activation markers on T cells infiltrating melanoma metastases after therapy with dinitrophenyl-conjugated vaccine. Cancer Immunol Immunother. 1994 Sep; 39(3):141-7.
-
Berd D, Maguire HC, Mastrangelo MJ. Treatment of human melanoma with a hapten-modified autologous vaccine. Ann N Y Acad Sci. 1993 Aug 12; 690:147-52.